Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 6Other hematologic neoplasm 5Thoracic 4Genitourinary 4Plasma cell 2Gynecologic 2Gastrointestinal 2CNS 2Breast 2Other solid neoplasm 1Myeloid 1Dermatologic 1

Conditions

Nose Neoplasms 1Esthesioneuroblastoma, Olfactory 1Dyslipidemias 1Central Nervous System Neoplasms 1

Interventions

Temozolomide 299Radiotherapy 219Bevacizumab 139Carboplatin 91Cyclophosphamide 88Etoposide 82Filgrastim 72Vincristine 69Irinotecan 69Magnetic Resonance Spectroscopy 65Cisplatin 59Radiation 58Radiosurgery 53Surgical Procedures, Operative 41Peripheral Blood Stem Cell Transplantation 40Topotecan 39Doxorubicin 39Lomustine 37Carmustine 36sargramostim 35Granulocyte Colony-Stimulating Factor 35Melphalan 34Nivolumab 32Chemotherapy, Adjuvant 32Radiotherapy, Intensity-Modulated 29Isotretinoin 29Everolimus 29Erlotinib Hydrochloride 27Thiotepa 25Vorinostat 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Electrocardiography × CNS × Clear all
NCT05012098 2025-08-08

Phase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON).

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
11 enrolled 14 charts
CNS

Nose Neoplasms, Esthesioneuroblastoma, Olfactory

NCT05641636 2022-12-07

Cardiovascular Disorders and Risk Factors in Childhood Cranial and Craniospinal Tumors Survivors

I.M. Sechenov First Moscow State Medical University

Completed
60 enrolled
CNS

Central Nervous System Neoplasms, Dyslipidemias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡